Advances in Allergen Immunotherapy and Safety

Area of Science:

• Immunology
• Allergy Treatment

Background:

• Allergen immunotherapy (AIT) is a treatment strategy that modifies immune responses to allergies.
• AIT is a long-term approach (3 months to 3 years) applicable to allergic rhinitis, asthma, food allergies, and insect venom allergies.
• The Food and Drug Administration (FDA) has approved the first peanut oral immunotherapy (OIT).

Purpose of the Study:

• To review published literature on allergen immunotherapy (AIT).
• To discuss AIT mechanisms, administration routes, and safety.
• To highlight challenges in determining effective AIT types and administration routes for various allergens.

Main Methods:

• Literature review of published studies on allergen immunotherapy.
• Analysis of existing knowledge regarding AIT mechanisms, administration routes, and safety profiles.

Main Results:

• AIT is an established treatment for several allergic conditions.
• Various administration routes exist for AIT.
• The development of effective AIT for different allergens and optimal administration routes remains a challenge.

Conclusions:

• Allergen immunotherapy is a viable long-term treatment for allergies.
• Further research is needed to optimize AIT efficacy and administration for diverse allergens.
• Safety and effectiveness of AIT are key considerations in its application.